Clinical trial Recruiting at 1 site Observational Ages 35 to 55 Women only

Impact of uterine fibroids on pelvic floor function

Official title: Prospective Clinical Trial on the Impact of Uterine Fibromatosis Surgery on Pelvic Floor.

Run by Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07180524 · Data updated 2026-11-12

This observational study will see if uterine fibroids are linked to urinary and other pelvic floor symptoms in women with symptomatic intramural or subserosal fibroids who are scheduled for hysterectomy or myomectomy.

More Pelvic Floor Dysfunction trials

Quick facts

Study typeObservational
Ages35 Years to 55 Years
SexWomen only
Enrollment200 (estimated)
SponsorFondazione IRCCS Policlinico San Matteo di Pavia
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Pavia, Pavia)
StatusRecruiting
StartedJune 30, 2024
Main results expectedDecember 31, 2028
Study endsDecember 31, 2029
Registry record updatedSeptember 18, 2025
Trial IDNCT07180524 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18–55 with symptomatic intramural or subserosal uterine fibroids documented by ultrasound who are scheduled for hysterectomy or myomectomy are ideal candidates.

Probably not a fit

Pregnant or postmenopausal women, those with suspected malignancy, active cancer, prior chemo/radiotherapy, or a history of pelvic static disorders (and asymptomatic women) are excluded and are unlikely to benefit from this study's findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational study enrolling women with symptomatic intramural or subserosal uterine fibroids mapped by ultrasound who are scheduled for hysterectomy or myomectomy. Investigators will collect clinical data and symptom information related to urinary, defecatory, and pelvic-perineal dysfunction prior to surgery to estimate prevalence and patterns of symptoms. Patients with suspected malignancy, active tumors, prior chemo/radiotherapy, pregnancy, age under 18 or over 55, or prior pelvic static disorders are excluded. The work is being conducted at a single center (Fondazione IRCCS Policlinico San Matteo, Pavia, Italy) and does not involve an interventional treatment arm.

Why it matters

Potential benefit: If successful, the findings could help clinicians better recognize and manage urinary and pelvic floor symptoms in women with fibroids and inform surgical decision-making.

How similar studies have gone: Previous observational studies have reported variable links between fibroids and urinary symptoms, so while related work exists the relationship is still incompletely characterized.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Symptomatic uterine fibromatosis with intramural and/or subserosal myomas identified by ultrasound and topographically mapped
* Patients with scheduled hysterectomy or myomectomy

Exclusion Criteria:

* suspicion of malignant lesion.
* active tumors
* previous history of chemotherapy or radiotherapy
* pregnancy
* age \<18 years or \>55 years (postmenopause)
* history of pelvic static disorders prior to surgery

Where it's running

  • Fondazione IRCCS Policlinico San Matteo, SC Ostetricia e Ginecologia 1
    Pavia, Pavia, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.